VANGL2 and neoplasm: In basal breast cancer, the archetypal Wnt/PCP protein VANGL PCP protein 2 (VANGL2) is upregulated and is associated with poor prognosis and tumour growth through the VANGL2‐p62/SQSTM1‐JNK pathway.22